UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 409

Sortiert nach

Circulating exosomal miR‐92b: Its role for cancer immunoediting and clinical value for prediction of posttransplant hepatocellular carcinoma recurrence

American journal of transplantation, 2019-12, Vol.19 (12), p.3250-3262

2019

Link zum Volltext

Verfügbarkeit prüfen

East Asia expert opinion on treatment initiation for chronic hepatitis B

Alimentary pharmacology & therapeutics, 2020-11, Vol.52 (10), p.1540-1550

2020

Link zum Volltext

Verfügbarkeit prüfen

Recent progress in TGF-β inhibitors for cancer therapy

Biomedicine & pharmacotherapy, 2021-02, Vol.134, p.111046-111046, Article 111046

2021

Link zum Volltext

Verfügbarkeit prüfen

Hepatitis B virus relapse rates in chronic hepatitis B patients who discontinue either entecavir or tenofovir

Alimentary pharmacology & therapeutics, 2019-01, Vol.49 (2), p.218-228

2019

Link zum Volltext

Verfügbarkeit prüfen

Clinical Study of Single‐Stranded Oligonucleotide RO7062931 in Healthy Volunteers and Patients With Chronic Hepatitis B

Hepatology (Baltimore, Md.), 2021-10, Vol.74 (4), p.1795-1808

2021

Link zum Volltext

Verfügbarkeit prüfen

Brivanib Versus Sorafenib As First-Line Therapy in Patients With Unresectable, Advanced Hepatocellular Carcinoma: Results From the Randomized Phase III BRISK-FL Study

Journal of clinical oncology, 2013-10, Vol.31 (28), p.3517-3524

2013

Link zum Volltext

Verfügbarkeit prüfen

Higher rate of HBsAg loss after discontinuation of tenofovir than entecavir in patients with chronic hepatitis B

Alimentary pharmacology & therapeutics, 2023-08, Vol.58 (3), p.334-345

2023

Link zum Volltext

Verfügbarkeit prüfen

The role of hepatitis B virus core‐related antigen in predicting hepatitis B virus relapse after cessation of entecavir in hepatitis B e antigen‐negative patients

Journal of viral hepatitis, 2021-08, Vol.28 (8), p.1141-1149

2021

Link zum Volltext

Verfügbarkeit prüfen

Earlier and Higher Rate of Hepatitis B Virus Relapse After Discontinuing Tenofovir Versus Entecavir in Hepatitis B e Antigen-Positive Patients

The Journal of infectious diseases, 2022-06, Vol.225 (11), p.1974-1981

2022

Link zum Volltext

Verfügbarkeit prüfen

Letter: tenofovir versus entecavir for hepatocellular carcinoma prevention in chronic hepatitis B‐related compensated cirrhosis—authors' reply

Alimentary pharmacology & therapeutics, 2021-05, Vol.53 (9), p.1042-1043

2021

Link zum Volltext

Verfügbarkeit prüfen

Five‐year comparative risk of hepatocellular carcinoma development under entecavir or tenofovir treatment‐naïve patients with chronic hepatitis B‐related compensated cirrhosis in Taiwan

Alimentary pharmacology & therapeutics, 2020-12, Vol.52 (11-12), p.1695-1706

2020

Link zum Volltext

Verfügbarkeit prüfen

Incidence and predictors of retreatment in chronic hepatitis B patients after discontinuation of entecavir or tenofovir treatment

PloS one, 2019-10, Vol.14 (10), p.e0222221-e0222221

2019

Link zum Volltext

Verfügbarkeit prüfen

The Incidence of Hepatitis B Surface Antigen Loss Between Hepatitis B E Antigen-Negative Noncirrhotic Patients Who Discontinued or Continued Entecavir Therapy

The Journal of infectious diseases, 2019-04, Vol.219 (10), p.1624-1633

2019

Link zum Volltext

Verfügbarkeit prüfen

Albumin‐Bilirubin grade predicts prognosis of HCC patients with sorafenib use

Journal of gastroenterology and hepatology, 2017-12, Vol.32 (12), p.1975-1981

2017

Link zum Volltext

Verfügbarkeit prüfen

Hepatitis B virus-related hepatocellular carcinoma has superior overall survival compared with other etiologies

PloS one, 2024, Vol.19 (3), p.e0290523-e0290523

2024

Link zum Volltext

Verfügbarkeit prüfen

Course and predictors of posttraumatic stress-related symptoms among family members of deceased ICU patients during the first year of bereavement

Critical care (London, England), 2021-08, Vol.25 (1), p.282-282, Article 282

2021

Link zum Volltext

Verfügbarkeit prüfen

The ALBI Grade is a Good Predictive Model for Very Late Recurrence in Patients with Hepatocellular Carcinoma Undergoing Primary Resection

World journal of surgery, 2020, Vol.44 (1), p.247-257

2020

Link zum Volltext

Verfügbarkeit prüfen

HDGF stimulates liver tumorigenesis by enhancing reactive oxygen species generation in mitochondria

The Journal of biological chemistry, 2023-11, Vol.299 (11), p.105335-105335, Article 105335

2023

Link zum Volltext

Verfügbarkeit prüfen

Decreased succinate dehydrogenase B in human hepatocellular carcinoma accelerates tumor malignancy by inducing the Warburg effect

Scientific reports, 2018-02, Vol.8 (1), p.3081-16, Article 3081

2018

Link zum Volltext

Verfügbarkeit prüfen

Ability of the post-operative ALBI grade to predict the outcomes of hepatocellular carcinoma after curative surgery

Scientific reports, 2020-04, Vol.10 (1), p.7290-7290, Article 7290

2020

Link zum Volltext

Verfügbarkeit prüfen

Circulating microRNAs as biomarkers for diagnosis of early hepatocellular carcinoma associated with hepatitis B virus

International journal of cancer, 2016-02, Vol.138 (3), p.714-720

2016

Link zum Volltext

Verfügbarkeit prüfen

Gut Microbiota Dysbiosis in Patients with Biopsy-Proven Nonalcoholic Fatty Liver Disease: A Cross-Sectional Study in Taiwan

Nutrients, 2020-03, Vol.12 (3), p.820

2020

Link zum Volltext

Verfügbarkeit prüfen

Morphomic Signatures Derived from Computed Tomography Predict Hepatocellular Carcinoma Occurrence in Cirrhotic Patients

Digestive diseases and sciences, 2020-07, Vol.65 (7), p.2130-2139

2020

Link zum Volltext

Verfügbarkeit prüfen

The change in liver stiffness, controlled attenuation parameter and fibrosis-4 index for chronic hepatitis C patients with direct-acting antivirals

PloS one, 2019-04, Vol.14 (4), p.e0214323-e0214323

2019

Link zum Volltext

Verfügbarkeit prüfen

APRI and FIB-4 in the evaluation of liver fibrosis in chronic hepatitis C patients stratified by AST level

PloS one, 2018-06, Vol.13 (6), p.e0199760-e0199760

2018

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 409

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(376)
Mit Volltextzugriff
(381)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Circulating exosomal miR‐92b: Its role for cancer immunoediting and clinical value for prediction of posttransplant hepatocellular carcinoma recurrence

East Asia expert opinion on treatment initiation for chronic hepatitis B

Recent progress in TGF-β inhibitors for cancer therapy

Hepatitis B virus relapse rates in chronic hepatitis B patients who discontinue either entecavir or tenofovir

Clinical Study of Single‐Stranded Oligonucleotide RO7062931 in Healthy Volunteers and Patients With Chronic Hepatitis B

Brivanib Versus Sorafenib As First-Line Therapy in Patients With Unresectable, Advanced Hepatocellular Carcinoma: Results From the Randomized Phase III BRISK-FL Study

Higher rate of HBsAg loss after discontinuation of tenofovir than entecavir in patients with chronic hepatitis B

The role of hepatitis B virus core‐related antigen in predicting hepatitis B virus relapse after cessation of entecavir in hepatitis B e antigen‐negative patients

Earlier and Higher Rate of Hepatitis B Virus Relapse After Discontinuing Tenofovir Versus Entecavir in Hepatitis B e Antigen-Positive Patients

Letter: tenofovir versus entecavir for hepatocellular carcinoma prevention in chronic hepatitis B‐related compensated cirrhosis—authors' reply

Five‐year comparative risk of hepatocellular carcinoma development under entecavir or tenofovir treatment‐naïve patients with chronic hepatitis B‐related compensated cirrhosis in Taiwan

Incidence and predictors of retreatment in chronic hepatitis B patients after discontinuation of entecavir or tenofovir treatment

The Incidence of Hepatitis B Surface Antigen Loss Between Hepatitis B E Antigen-Negative Noncirrhotic Patients Who Discontinued or Continued Entecavir Therapy

Albumin‐Bilirubin grade predicts prognosis of HCC patients with sorafenib use

Hepatitis B virus-related hepatocellular carcinoma has superior overall survival compared with other etiologies

Course and predictors of posttraumatic stress-related symptoms among family members of deceased ICU patients during the first year of bereavement

The ALBI Grade is a Good Predictive Model for Very Late Recurrence in Patients with Hepatocellular Carcinoma Undergoing Primary Resection

HDGF stimulates liver tumorigenesis by enhancing reactive oxygen species generation in mitochondria

Decreased succinate dehydrogenase B in human hepatocellular carcinoma accelerates tumor malignancy by inducing the Warburg effect

Ability of the post-operative ALBI grade to predict the outcomes of hepatocellular carcinoma after curative surgery

Circulating microRNAs as biomarkers for diagnosis of early hepatocellular carcinoma associated with hepatitis B virus

Gut Microbiota Dysbiosis in Patients with Biopsy-Proven Nonalcoholic Fatty Liver Disease: A Cross-Sectional Study in Taiwan

Morphomic Signatures Derived from Computed Tomography Predict Hepatocellular Carcinoma Occurrence in Cirrhotic Patients

The change in liver stiffness, controlled attenuation parameter and fibrosis-4 index for chronic hepatitis C patients with direct-acting antivirals

APRI and FIB-4 in the evaluation of liver fibrosis in chronic hepatitis C patients stratified by AST level

Suchergebnisse filtern